Despite a decade of gradual growth, R&D spending in Europe outpaced by the US
New research published today by EFPIA provides in-depth analysis of the economic footprint
New research published today by EFPIA provides in-depth analysis of the economic footprint
It is exciting to see the advances in science, and the diversity in innovation coming from pharmaceutical companies to address these health challenges
Organizational structures must be adjusted to support innovation and establish high-quality standards.
We are standing at a critical point where the challenges of European healthcare threaten the socio-economic stability of our societies